| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/22/2005 | US6858712 Cloning and expression of HTLV-III DNA |
| 02/22/2005 | US6858710 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 02/22/2005 | US6858709 Component of von Hippel-Lindau tumor suppressor complex and SCF ubiquitin ligase |
| 02/22/2005 | US6858706 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 02/22/2005 | US6858591 2-amino-3-hydroxy-3-uridyl-propanoic acid ester derivatives |
| 02/22/2005 | US6858590 With an antigen that has an epitope of hepatitis c virus |
| 02/22/2005 | US6858587 Use of Factor VII and/or Factor VIIa for reducing apoptosis of a cell |
| 02/22/2005 | US6858586 Pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation |
| 02/22/2005 | US6858585 Cyclic depsipeptides and drugs containing the same as the active ingredient |
| 02/22/2005 | US6858584 For therapy of bacterial disease in a mammal; side effect reduction |
| 02/22/2005 | US6858583 For regulating the abnormal stem cell cycle and for accelerating the post-chemotherapy peripheral blood cell recovery |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858580 Immobilization of drugs |
| 02/22/2005 | US6858579 Comprising the amino acid sequence AMVSE and not EQEYVQTV; for inhibiting leukocyte migration and diseases such as gout, arthritis, asthma, reperfusion injury |
| 02/22/2005 | US6858578 Chimeric proteins for use in transport of a selected substance into cells |
| 02/22/2005 | US6858577 For therapy of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angiogenesis related disorders, cancer, and neurodegenerative disorders |
| 02/22/2005 | US6858576 Methods for regulating gastrointestinal motility |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858427 Sphingosine kinases |
| 02/22/2005 | US6858422 Lipase genes |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858419 Comprises phosphorylating protein for diagnosis, prognosis, drug screening, clinical monitoring and treatment of hypertension |
| 02/22/2005 | US6858418 Polypeptide for use in the treatment of cardiovascular and cell proliferation disorders |
| 02/22/2005 | US6858416 Human desaturase gene and uses thereof |
| 02/22/2005 | US6858410 Process for making antifusogenic fusion peptides that form inclusion bodies |
| 02/22/2005 | US6858409 Identifying nucleotide sequences which code modulator for treating arthritis, inflammatory bowel, sepsis and adult respiratory distress diseases; immunosuppressant |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858402 System for discovering and producing polypeptides that cause TNF receptor shedding |
| 02/22/2005 | US6858396 Amino acids where primary amine group is replaced by azide; use in peptides screening for bioactivity, crossing blood-brain barrier, increasing selectivity; treating brain disorders |
| 02/22/2005 | US6858395 Diagnoss and treatment of muscular disorders; obtain tissue sample, detect preferential gene expression, amplified transcription of prferential gene indicates muscular disorder |
| 02/22/2005 | US6858390 Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes |
| 02/22/2005 | US6858383 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 02/22/2005 | US6858236 Nutriceutical and drug compositions containing a plant extract or concentrate from the genus Lycopersicon (tomato); bone disorders, e.g., Paget's disease, tumor-induced bone disease or particularly osteoporosis; metabolic disorders |
| 02/22/2005 | US6858234 Extracting enzyme inhibitors from wheat flour or gluten for treating hyperglycemia, diabetes, hyperlipemia and arteriosclerosis |
| 02/22/2005 | US6858222 Fabrication of drug loaded biodegradable polymer fibers |
| 02/22/2005 | US6858215 For therapy of calluses and fissures, helomas (corns), keratoses (papules) |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/22/2005 | US6858209 Means for detecting bacteria of the taylorella equigenitalis species and their biological applications |
| 02/22/2005 | US6858208 Increased muscle tissue; transgenic animal |
| 02/22/2005 | US6858207 Methods and materials relating to novel CD39-like polypeptides |
| 02/22/2005 | US6858206 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 02/22/2005 | US6858204 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/22/2005 | US6858201 Methods for treating fingernails and toenails |
| 02/22/2005 | US6858199 High efficient delivery of a large therapeutic mass aerosol |
| 02/22/2005 | CA2271232C Modified protein c and methods of use thereof |
| 02/22/2005 | CA2236256C A pharmaceutical composition for the treatment of autoimmune diseases |
| 02/22/2005 | CA2220434C The use of epidermal growth factor as a gastrointestinal therapeutic agent |
| 02/22/2005 | CA2185352C Novel muteins of ifn-.beta. |
| 02/22/2005 | CA2184581C Improved dnase liquid solutions |
| 02/22/2005 | CA2150251C Lyospheres comprising gonadotropin |
| 02/22/2005 | CA2083243C Process for the production of a virus-free concentrate of thrombin |
| 02/17/2005 | WO2005015205A2 Use of sap |
| 02/17/2005 | WO2005015159A2 Methods for modulating a drug-related effect or behavior |
| 02/17/2005 | WO2005014849A2 Genes associated with responses to neuropathic pain |
| 02/17/2005 | WO2005014838A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/17/2005 | WO2005014835A1 Use of fak-related non-kinase in the manufacture of a medicament for the inhibition of stenosis and restenosis |
| 02/17/2005 | WO2005014822A2 Novel therapeutic fusion proteins |
| 02/17/2005 | WO2005014818A1 Gene overexpressed in cancer |
| 02/17/2005 | WO2005014816A1 Antigens for immunocontraception |
| 02/17/2005 | WO2005014815A1 siRNA BASED METHODS FOR TREATING ALZHEIMER’S DISEASE |
| 02/17/2005 | WO2005014812A2 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
| 02/17/2005 | WO2005014811A2 RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/17/2005 | WO2005014806A2 Conserved hbv and hcv sequences useful for gene silencing |
| 02/17/2005 | WO2005014798A2 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells |
| 02/17/2005 | WO2005014783A2 Reducing axon degeneration with proteasome inhibitors |
| 02/17/2005 | WO2005014775A2 Raav compositions and methods for delivery of human factor vii polypeptides and treatment of hemophilia a |
| 02/17/2005 | WO2005014644A1 Gene expressed in breast cancer and methods of use |
| 02/17/2005 | WO2005014642A2 Novel multifunctional cytokines |
| 02/17/2005 | WO2005014641A2 Ciliary neurotrophic factor variants |
| 02/17/2005 | WO2005014639A2 Periodic antimicrobial peptides |
| 02/17/2005 | WO2005014637A1 Apoptosis inhibitors |
| 02/17/2005 | WO2005014634A1 A gene and uses therefor |
| 02/17/2005 | WO2005014628A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof. |
| 02/17/2005 | WO2005014625A1 Polypeptides having brain disposition activity and utilization of the same |
| 02/17/2005 | WO2005014621A1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 02/17/2005 | WO2005014619A2 Heparin-binding peptides and uses thereof |
| 02/17/2005 | WO2005014617A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 02/17/2005 | WO2005014612A1 Novel splice variant of ctla-4 |
| 02/17/2005 | WO2005014607A2 Antisense modulation of stearoyl-coa desaturase expression |
| 02/17/2005 | WO2005014049A2 Synthesis and application of new structural well defined branched polymers as conjugating agents for peptides |
| 02/17/2005 | WO2005014039A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |
| 02/17/2005 | WO2005014035A2 Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
| 02/17/2005 | WO2005014034A1 Stabilized formulation of parathyroid hormone |
| 02/17/2005 | WO2005014033A1 Use of human growth hormone in multiple system atrophy |
| 02/17/2005 | WO2005014032A2 Use of secretagogues like ghrelin in cancer cachexia and for stimulating appetite |
| 02/17/2005 | WO2005014031A1 Use of calcitonin in osteoarthritis |
| 02/17/2005 | WO2005014030A1 Method for treating lung diseases associated with ventilation-perfusion mismatches |
| 02/17/2005 | WO2005014029A2 Use of dg008, dg065, dg210 or dg 239 secreted protein products for preventing and treating pancreatic diseases, obesity or metabolic syndrome |
| 02/17/2005 | WO2005014028A1 Interleukin-20 for treating and diagnosing conditions associated with neovascularisation |
| 02/17/2005 | WO2005014027A1 Use of chemokines, and pharmaceutical preparations containing the same |
| 02/17/2005 | WO2005014026A2 Use of cxcl6 chemokine in the prevention or repair of cartilage defects |
| 02/17/2005 | WO2005014025A1 Formulation of albumin-free erythropoietin |
| 02/17/2005 | WO2005014023A1 Pharmaceutical combination of g-csf and plgf useful for blood stem cell |
| 02/17/2005 | WO2005014022A1 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 02/17/2005 | WO2005014021A2 Use of zkw peptide for preparing an inhibitor drug against platelet aggregation |
| 02/17/2005 | WO2005014014A1 Method for inhibiting bacterial colonisation |
| 02/17/2005 | WO2005014011A1 Use of smad 7 antisense oligonucleotides (odn) for the treatment of diseases mediated by the nuclear transcription factor nf-kb |
| 02/17/2005 | WO2005013980A1 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions. |
| 02/17/2005 | WO2005013933A1 Mucoadhesive composition comprising polyacrylate and chemoattractant |
| 02/17/2005 | WO2005013916A2 Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/pin in human cells |